Table of Contents
CONTENTS
Foreword
Norman Farnsworth
Introduction
Raymond Cooper and Fredi Kronenberg
I. Botanical Products – Selection and Quality Issues
Botanical Preparations: Achieving Quality Products
Steven Dentali
Pre-Clinical and Clinical Evidence for Botanical Interventions for Type 2 Diabetes
Joseph L. Evans
Botanicals in Dermatology and Skin Health
Juliane Reuter, Irmgard Merfort, Ute Wölfle, Günter Seelinger,
and Christoph M. Schempp
II. Botanical Products - Preclinical and Clinical Approaches
St. John's Wort: Quality Issues and Active Compounds.
Veronika Butterweck
Preclinical and Clinical Development of the Green Tea Catechin, Epigallocatechin
Gallate, in Treating HIV-1 Infection
Christina L. Nance and William T. Shearer
Curcuminoids from Curcuma longa in disease prevention and treatment
Vladimir Badmaev
Use of Standardized Mixtures of Paw Paw Extract (Asimina triloba) in Cancer Patients:
Case Studies
Jerry L. McLaughlin, Gina B. Benson, Tad A. Turgeon, and James W. Forsythe
Valerian and Hops: Synergy, Mode of Action and Clinical Evidence
Uwe Koetter
Development of Iberogast: Clinical Evidence for Multi-component Herbal Mixtures
Bettina Vinson
Biological Activity of Cranberry Proanthocyanidins: Effects on Oxidation, Microbial
Adherence, Inflammation, and Health
Jess D. Reed and Amy B. Howell
Cranberry Products Prevent Urinary Tract Infections in Women: Clinical Evidence
Michael Tempesta and Marilyn Barrett
III. Botanical Products - A Practitioners View
Chaste Tree Extract in Women’s Health: A Critical Review
Tieraona Low Dog